Using the FIT-only strategy, a threshold of ≥200 ng Hb/g would have required 357 colonoscopies to detect 76 cancers, resulting in a cost-per-cancer of EUR 2489 (Table 10). This evidence concerns the gene GSTM1 and cancer.